What’s Going On With Chemical Giant Dow Shares Today?
DOW's Q1 FY24 results beat expectations with sales up 1% and EPS at $0.56. Company remains confident in long-term potential and shareholder value.
Walgreens Expands Specialty Pharmacy Business To Include Gene and Cell Services: Details
Walgreens Boots Alliance elevates its specialty pharmacy services with the launch of Walgreens Specialty Pharmacy. With a focus on patient outcomes and partnerships, the initiative introduces gene and cell therapy solutions, anchored by an Innovation Center in Pittsburgh.
Verizon Poised For Growth, Strategic Network Upgrades, Strong Momentum To Drive Future Success: Analyst
Timothy Horan maintained Outperform rating and $48 price target for Verizon due to strong momentum, network upgrades, and improved management. Q1 results impacted by price increases, but outlook is stable.
Verizon’s Q1: Flat Revenue, Bump In Free Cash Flow And Stable 2024 Outlook
Verizon Communications Inc. announces slight sales growth in Q1 2024, hitting $32.98 billion, with adjusted EPS topping expectations at $1.15. Despite missing sales consensus, wireless service revenue rose by 3.3% year-on-year, driven by strategic pricing and subscriber growth. The company sees strong broadband additions and reiterates optimistic financial guidance for the year.
What’s Going On With Post-It Maker 3M Stock Today?
3M Company reveals final approval of settlement with US water suppliers for PFAS in drinking water. Apart from this, the company completed the spin-off of Solventum, which will begin trading on the New York Stock Exchange (NYSE) under the ticker symbol "SOLV."